Cochrane Corner: Addition of Long-Acting Beta2 Agonists or Long-Acting Muscarinic Antagonists Versus Doubling the Dose of Inhaled Corticosteroids (ICS) in Adolescents and Adults With Uncontrolled Asthma With Medium-Dose ICS

被引：0
|
作者：
Baigel, Rachel [1 ]
Gregory, Ian [1 ]
机构：
[1] North Middlesex Hosp, London, England
来源：
CLINICAL AND EXPERIMENTAL ALLERGY | 2024年 / 54卷 / 09期
关键词：
D O I：
10.1111/cea.14554
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：647 / 650
页数：4
相关论文
共 50 条
  • [1] Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis
    Oba, Yuji
    Anwer, Sumayya
    Patel, Tarang
    Maduke, Tinashe
    Dias, Sofia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (08):
  • [2] Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2 - agonists (LABA) for adults with asthma
    Kew, Kayleigh M.
    Evans, David J. W.
    Allison, Debbie E.
    Boyter, Anne C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (06):
  • [3] Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
    Evans, David J. W.
    Kew, Kayleigh M.
    Anderson, Debbie E.
    Boyter, Anne C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (07):
  • [4] Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
    Kew, Kayleigh M.
    Dahri, Karen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
  • [5] Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children
    Ducharme, Francine M.
    Chroinin, Muireann Ni
    Greenstone, Ilana
    Lasserson, Toby J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [6] The addition of long-acting beta-agonists to inhaled corticosteroids in asthma
    Sears, Malcolm R.
    CURRENT OPINION IN PULMONARY MEDICINE, 2011, 17 (01) : 23 - 28
  • [7] Characterization Of COPD Patients Treated With Inhaled Triple Therapy Containing Inhaled Corticosteroids [ics], Long-Acting Beta2-Agonists [laba], And Long-Acting Muscarinic Antagonists [lama] In The Uk
    Mullerova, H.
    Maskell, J.
    Meeraus, W. H.
    Galkin, D.
    Albers, F. C.
    Gait, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [8] Effect of Inhaled Corticosteroids (ICS) Vs. Inhaled Corticosteroid with Long-Acting Beta2 Agonists (ICS/LABA) On Asthma Control: Results From National Asthma Survey
    Talreja, Neetu
    Ledford, Dennis K.
    Lockey, Richard F.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB230 - AB230
  • [9] Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease
    van Geffen, Wouter H.
    Tan, Daniel J.
    Walters, Julia A. E.
    Walters, E. Haydn
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (12):
  • [10] Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease
    Tan, Daniel J.
    White, Clinton J.
    Walters, Julia A. E.
    Walters, E. Haydn
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (11):
12345